Urinary biomarkers in children with urinary tract infections with and without reflux on antibacterial prophylaxis with cefaclor

Clinical Drug Investigation

Volumn 18, Issue 6, 1999, Pages 461-466

  Pizzini, C ^a   Mussap, M ^b   Mangiarotti, P ^a   Plebani, M ^b,c   Selmin, R ^b   Fanos, V ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c Biochemical Research Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 MICROGLOBULIN; CEFACLOR; CREATININE; N ACETYL BETA GLUCOSAMINIDASE; UREA;

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYSTOURETHROGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; MICTURITION; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; VESICOURETERAL REFLUX;

EID: 0033378918     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199918060-00005     Document Type: Article

References (39)

1. 1. Zelicovich I, Adelman RD, Nancarrow PA. Urinary tract infections. An update. West J Med 1992; 157: 554-61
2. 2. Fanos V, Khoory BJ, Vecchini S, et al. Vesicoureteric reflux in paediatrics [in Italian]. Minerva Pediatr 1998; 50: 367-74
3. 3. Mangiarotti P, Pizzini C, Fanos V. Antibiotic prophylaxis in children with relapsing urinary tract infections. J Chemother 1999. In press
4. 4. Fanos V, Cataldi L. Antibacterial-induced nephrotoxicity in the newborn. Drug Saf 1999; 20 (3): 245-67
5. 5. Webster CA, Curran R, Towner KJ. Comparative in-vitro activity of cefaclor against urinary tract isolates of Escherichia coli. J Antimicrob Chemother 1996; 38: 59-66
6. 6. Seracini D, Materassi M, Danti M. Studio aperto non comparativo sull'efficacia e tollerabilità del cefaclor nella profilassi delle infezioni delle vie urinarie nel bambino. Pediatr Med Chir 1996; 18: 383-5
7. 7. Gérard M, Diakite B, Bedu A, et al. L'infection urinaire du nouveau-né. Arch Pediatr 1998; 5 Suppl. 3: 254-9
8. 8. Agbayani MM, Khan AJ, Kumar K, et al. Cefaclor therapy of urinary tract infections in infants and children. Curr Ther Res 1979; 26 (2): 141-4
9. 9. Canepa A, Galardi F, Gusmano R, et al. Efficacy and tolerability of long term oral cefaclor therapy in the prevention of urinary tract infections in infants and children. Curr Ther Res 1998; 59 (12): 873-80
10. 10. Norrby SR. Side effects of cephalosporins. Drugs 1987; 34 Suppl. 2: 105-20
11. 11. Mussap M, Fanos V, Cataldi L, et al. Urinary low molecular mass proteins and enzymes as early, non invasive markers of nephrotoxicity in the neonate. Eur J Lab Med 1998; 6 (1): 1-14
12. 12. Guder WG, Hoffman WW. Markers for the diagnosis and monitoring of renal tubular lesions. Clin Nephrol 1992; 38 (1): S3-S7
13. 13. Mussap M, Fanos V, Ruzzante N, et al. Urinary N-acetyl-β-D-glucosaminidase (NAG) and alpha 1 microglobulin excretion as an index of renal tubular dysfunction in the neonate. Eur J Lab Med 1997; 5 (3): 1-4
14. 14. Fanos V, Mussap M, Verlato G, et al. Evaluation of antibioticinduced nephrotoxicity in preterm newborns by determining urinary alpha-1 microglobulin. Pediatr Nephrol 1996; 10: 645-7
15. 15. Csàthy L, Pòcsi I. Urinary N-acetyl-β-D-glucosaminidase determination in newborns and children: Methods and diagnostic applications. Eur J Clin Chem Clin Biochem 1995; 33: 575-87
16. 16. Fanos V, Agostiniani R, Cataldi L, Vesicoureteric reflux: an update. Med Sur Ped 1999; 21: 1-5
17. 17. Cunha BA. Third generation cephalosporines: a review. Clin Ther 1992; 14: 616-52
18. 18. Ragnar Norrby S. Adverse reactions and interactions with newer cephalosporins and cephamycin antibiotics. Med Toxicol 1986; 1: 32-46
19. 19. Tune BM. Renal tubular transport and nephrotoxicity of betalactam antibiotics: structure-activity relationship. Miner Electrolyte Metab 1994; 20: 221-31
20. 20. Tune BM. Nephrotoxicity of beta-lactam antibiotics: mechanism and strategies for prevention. Pediatr Nephrol 1997; 11 (6): 768-72
21. 21. Kaloyanides GJ. Antibiotic related nephrotoxicity. Nephrol Dial Transplant 1994; 9 Suppl. 4: 130S-4S
22. 22. Morin JP, Fillastre JP, Vaillant R. In vitro effects of aminoglycosides and cephalosporins on rat kidney lysosomes. C R Seances Soc Biol Fil 1977; 171 (5): 1088-93
23. 23. Naruse T, Hirokawa N, Oike S, et al. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving armnoglycoside and cephalosporin drugs. Res Commun Chem Pathol Pharmacol 1981; 31 (2): 313-29
24. 24. Sourgens H, Derendorf H, Schifferer H. Pharmacokinetic profile of cefaclor. Int J Clin Pharmacol Ther 1997; 35 (9): 374-80
25. 25. Gentry LO. Cephalosporins in urinary tract infection. Drugs 1987; 34 Suppl. 2: 154-63
26. 26. Iravani A, Bischoff W. Antibiotic therapy for urinary tract infections. Am J Med 1992 Jun 22; 92 (6A): 95S-100S
27. 27. Asvanich K, Fugpholngam V, Srimuang S, et al. Cefaclor therapy in uncomplicated cystitis. J Med Assoc Thai 1997; 80 (11); 742-5
28. 28. Beghetti M, Wilson GJ, Bohn D, et al. Hypersensitivity myocarditis caused by an allergic reaction to cefaclor. J Pediatr 1998; 132 (1): 172-3
29. 29. Grouhi M, Hummel D, Roifman CM. Anaphylactic reaction to oral cefaclor in a child. Pediatrics 1999, 103 (4): 50
30. 30. Knowles S, Shapiro L, Shear NH. Serious dermatologic reactions in children, Curr Opin Pediatr 1997; 9 (4): 388-95
31. 31. Pommer W, Krause PH, Berg PA, et al. Acute interstitial nephritis and non-oliguric renal failure after cefaclor treatment. Klin Wochenschr 1986; 64 (6): 290-3
32. 32. Wang PI, Prime DJ, Hsu CY, et al. Effects of ureteral obstruction on the toxicity of cephalosporins in the rabbit kidney. J Infect Dis 1982; 145: 574-81
33. 33. Cataldi L, Fanos V. Neonatal urinary tract infections: diagnosis and treatment. In: Cataldi L, Fanos V, Simeoni U, editors. Neonatal Nephrology in Progress, Agorà, Lecce, 1996: 183-98
34. 34. Fanos V, Khoory BJ. Antimicrobial survey on urinary tract isolates from a pediatric department. J Chemother 1999; 11 (4): 20 -4
35. 35. Fanos V, Dall'Agnola A. Antibiotics in neonatal infections: a review. Drugs 1999 Sep; 58 (3): 405-27
36. 36. Brumfitt W, Hamilton-Miller JMT. Cefaclor into the millennium. J Chemother 1999; 11 (3): 163-78
37. 37. Price RG. The role of NAG (N-acetyl-β-D-Glucosaminidase) in the diagnosis of the kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 1992; 38 (1): S14-S 19
38. 38. Johnson CE, Vacca CV, Fattalar D, et al. Urinary N-acetyl-β-D-glucosaminidase and the selection of children for radiologic evaluation after urinary tracy infection. Pediatrics 1990; 86 (2): 211 -5
39. 39. Hanbury DC, Calvin J. Proteinuria and enzimuria in vesicoureteric reflux. Br J Urol 1992; 70: 603 -9